Page 8 - செயலில் மருந்து மூலப்பொருள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DRDO invites EoI to transfer technology of 2-DG drug for bulk production | India News

India News: The Defence Research and Development Organisation (DRDO), which developed 2-Deoxy-D- Glucose (2-DG), a drug used for treatment of Covid-19 patients,

Andhra pradeshTechnical assessment committeeInstitute of nuclear medicineDevelopment organisationDefence researchNuclear medicineAllied sciencesFirst come served basisActive pharmaceutical ingredientDrug licensing authoritiesNdia newsNdia news todayOday newsGoogle newsReaking news2 dg drug

CSIR begins clinical trials for Niclosamide drug as Covid-19 treatment

New Delhi [India], June 6 (ANI): Council of Scientific and Industrial Research (CSIR) along and Laxai Life Sciences Pvt. Ltd. on Sunday initiated Phase-II clinical trial for anti-helminitic drug Niclosamide for treatment of Covid-19.

Andhra pradeshNew delhiSrivari chandrashekharRam upadhayayaShekharc mandeLaxai life sciences pvtCouncil of scientificLaxai life sciencesIndustrial researchDirector generalActive pharmaceutical ingredientR shekharc mandeR ram upadhayayaPhase ii clinical trialஆந்திரா பிரதேஷ்புதியது டெல்ஹி

CSIR Begins Phase-II Trial For Using Niclosamide - A Drug To Treat Tapeworm Infection As Covid-19 Remedy

CSIR Begins Phase-II Trial For Using Niclosamide - A Drug To Treat Tapeworm Infection As Covid-19 Remedy
swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.

Jammu and kashmirCity ofUnited kingdomRam vishwakarmaLaxai life sciencesKing collegeActive pharmaceutical ingredientCovid 19ஜம்மு மற்றும் காஷ்மீர்நகரம் ஆஃப்ஒன்றுபட்டது கிஂக்டம்ரேம் விஸ்வகர்மாலக்சை வாழ்க்கை அறிவியல்கிங் கல்லூரிசெயலில் மருந்து மூலப்பொருள்

City firm partners with CSIR for clinical trial of Niclosamide

‘Niclosamide is generic, affordable and easily available’

Jammu and kashmirAndhra pradeshCity ofUnited kingdomRam vishwakarmaShekharc mandeRam upadhayayaNational centre for biological sciencesLaxai life sciences pvtLaxai life sciencesCouncil of scientific industrial researchCsir indian institute of integrative medicineCsir indian institute of chemical technologyKing collegeIndustrial researchGeneral shekhar

CSIR begins clinical trials of Niclosamide for Covid treatment

The CSIR, in collaboration with Laxai Life Sciences, has initiated Phase 2 clinical trial of anti-helminitic drug Niclosamide for treatment of Covid-19.The trial is a multi-centric, randomised, open label clinical study to evaluate efficacy, .

Andhra pradeshNew delhiSrivari chandrashekharShekharc mandeRam upadhayayaLaxai life sciencesGeneral shekharDirector srivari chandrashekharActive pharmaceutical ingredientஆந்திரா பிரதேஷ்புதியது டெல்ஹிஸ்ரீவாரி சந்திரசேகர்லக்சை வாழ்க்கை அறிவியல்ஜநரல் சேகர்செயலில் மருந்து மூலப்பொருள்